These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

846 related articles for article (PubMed ID: 27658522)

  • 41. Dental opioid prescribing practices and risk mitigation strategy implementation: Identification of potential targets for provider-level intervention.
    McCauley JL; Leite RS; Melvin CL; Fillingim RB; Brady KT
    Subst Abus; 2016; 37(1):9-14. PubMed ID: 26675303
    [TBL] [Abstract][Full Text] [Related]  

  • 42. An Experimental Test of the Effectiveness of Unsolicited Reporting by a Prescription Drug Monitoring Program in Reducing Inappropriate Acquisition of Opioids.
    McDonald DC; Carlson KE; Jalbert SK
    Pain Med; 2019 May; 20(5):944-954. PubMed ID: 29868715
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Mapping prescription drug monitoring program data to self-report measures of non-medical prescription opioid use in community pharmacy settings.
    Charron E; Brooks JH; Peterson KT; Akinwolere OG; Winhusen T; Cochran G
    Res Social Adm Pharm; 2023 Aug; 19(8):1171-1177. PubMed ID: 37142474
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The effects of state rules on opioid prescribing in Indiana.
    Al Achkar M; Grannis S; Revere D; MacKie P; Howard M; Gupta S
    BMC Health Serv Res; 2018 Jan; 18(1):29. PubMed ID: 29347984
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effects of mandatory prescription drug monitoring program (PDMP) use laws on prescriber registration and use and on risky prescribing.
    Strickler GK; Zhang K; Halpin JF; Bohnert ASB; Baldwin GT; Kreiner PW
    Drug Alcohol Depend; 2019 Jun; 199():1-9. PubMed ID: 30954863
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The prescription drug monitoring program in a multifactorial approach to the opioid crisis: PDMP data, Pennsylvania, 2016-2020.
    Adalbert JR; Syal A; Varshney K; George B; Hom J; Ilyas AM
    BMC Health Serv Res; 2023 Apr; 23(1):364. PubMed ID: 37046254
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of Florida's Prescription Drug Monitoring Program and Pill Mill Laws on Opioid Prescribing and Use.
    Rutkow L; Chang HY; Daubresse M; Webster DW; Stuart EA; Alexander GC
    JAMA Intern Med; 2015 Oct; 175(10):1642-9. PubMed ID: 26280092
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Characteristics of state prescription drug monitoring programs: a state-by-state survey.
    Manasco AT; Griggs C; Leeds R; Langlois BK; Breaud AH; Mitchell PM; Weiner SG
    Pharmacoepidemiol Drug Saf; 2016 Jul; 25(7):847-51. PubMed ID: 27061342
    [TBL] [Abstract][Full Text] [Related]  

  • 49. "1,000 conversations I'd rather have than that one:" A qualitative study of prescriber experiences with opioids and the impact of a prescription drug monitoring program.
    Zavodnick J; Wickersham A; Petok A; Worster B; Leader A
    J Addict Dis; 2022; 40(4):527-537. PubMed ID: 35133217
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The impact of automatic physician review of prescription drug monitoring program data on opioid prescribing in a Maryland statewide hospital system.
    Stryckman B; Schoenbaum A; Klein J; Chasm R; Onukwugha E; Dezman ZD
    J Opioid Manag; 2022; 18(6):547-556. PubMed ID: 36523206
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Opioid Prescribing After Implementation of Single Click Access to a State Prescription Drug Monitoring Program Database in a Health System's Electronic Health Record.
    Weiner SG; Kobayashi K; Reynolds J; Chan K; Kelly R; Wakeman S; Reddy P; Young LD
    Pain Med; 2021 Oct; 22(10):2218-2223. PubMed ID: 33561288
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A Systematic Review of Interventions and Programs Targeting Appropriate Prescribing of Opioids.
    Moride Y; Lemieux-Uresandi D; Castillon G; de Moura CS; Pilote L; Faure M; Bernartsky S
    Pain Physician; 2019 May; 22(3):229-240. PubMed ID: 31151331
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prescription Drug Monitoring Programs: Relationships Among Program Awareness, Use, and State Mandates.
    Williams KS; Magalotti S; Schrouder K; Knox M; Feldman L; Ujwal D; Lynch D
    J Pain Palliat Care Pharmacother; 2018; 32(2-3):129-133. PubMed ID: 30198819
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Patterns of prescription of opioid analgesics in Hôtel-Dieu de France of Beyrouth].
    Noufi P; Khoury E; Ayoub E; Naccache N; Richa S
    Encephale; 2016 Dec; 42(6):511-516. PubMed ID: 27776797
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Changes in opioid agonist treatment initiation among people prescribed opioids for pain following voluntary and mandatory prescription drug monitoring program implementation: A time series analysis.
    Picco L; Xia T; Bell JS; Pearce C; Buchbinder R; Lubman DI; Nielsen S
    Drug Alcohol Rev; 2023 Nov; 42(7):1639-1646. PubMed ID: 37798947
    [TBL] [Abstract][Full Text] [Related]  

  • 56. How Are Real-time Opioid Prescribing Cognitions by Emergency Providers Influenced by Reviewing the State Prescription Drug Monitoring Program?
    Landau A; Lynch M; Callaway C; Suffoletto B
    Pain Med; 2019 May; 20(5):955-960. PubMed ID: 29762757
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The Effect of a Statewide Mandatory Prescription Drug Monitoring Program on Opioid Prescribing by Emergency Medicine Providers Across 15 Hospitals in a Single Health System.
    Suffoletto B; Lynch M; Pacella CB; Yealy DM; Callaway CW
    J Pain; 2018 Apr; 19(4):430-438. PubMed ID: 29241835
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Changes in opioid prescribing after implementation of mandatory registration and proactive reports within California's prescription drug monitoring program.
    Castillo-Carniglia A; González-Santa Cruz A; Cerdá M; Delcher C; Shev AB; Wintemute GJ; Henry SG
    Drug Alcohol Depend; 2021 Jan; 218():108405. PubMed ID: 33234299
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Primary care provider perspectives on and utilization of a mandatory prescription drug monitoring program in New York City.
    Harocopos A; Allen B; Chernick R
    Fam Pract; 2022 Mar; 39(2):264-268. PubMed ID: 34268573
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effect of a legislative mandate on opioid prescribing for back pain in the emergency department.
    Khobrani M; Perona S; Patanwala AE
    Am J Emerg Med; 2019 Nov; 37(11):2035-2038. PubMed ID: 30824275
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 43.